Kelly Qiao

B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Raised $247,000,000.00 from Lilly Asia Ventures, Ally Bridge Group, T. Rowe Price, Janus Henderson Investors, LYFE Capital, Logos Capital, Piper Heartland Healthcare Capital, LifeSci Venture Partners, Medicxi and Surveyor Capital.